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ABSTRACT The aggregation of amyloid-b protein (Ab) in vivo is a critical pathological event in Alzheimer’s disease. Although
more and more evidence shows that the intermediate oligomers are the primary neurotoxic species in Alzheimer’s disease, the
particular structural features responsible for the toxicity of these intermediates are poorly understood. We measured the peptide
level solvent accessibility of multiple Ab(1-40) aggregated states using hydrogen exchange detected by mass spectrometry.
A gradual reduction in solvent accessibility, spreading from the C-terminal region to the N-terminal region was observed with
ever more aggregated states of Ab peptide. The observed hydrogen exchange protection begins with reporter peptides 20-34
and 35-40 in low molecular weight oligomers found in fresh samples and culminates with increasing solvent protection of reporter
peptide 1-16 in long time aged ﬁbrillar species. The more solvent exposed structure of intermediate oligomers in the N-termini
relative to well-developed ﬁbrils provides a novel explanation for the structure-dependent neurotoxicity of soluble oligomers
reported previously.
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Studies over the last two decades have accumulated a large
body of evidence in favor of the amyloid hypothesis, which
regards the cerebral Ab accumulation as the primary driving
force in Alzheimer’s disease pathology (1,2). Consequently,
the process of Ab aggregation and fibril formation has been
explored extensively in AD research (3–9). Two intriguing
but unresolved issues are the underlying molecular mecha-
nism by which in vivo generated Ab peptide forms
neurotoxic oligomers and fibrils, and the molecular basis
for the differences in neurotoxicity associated with different
aggregated forms, with an increasing emphasis on the inter-
mediate soluble oligomers (10–13). Clear elucidation of the
structural and kinetic aspects of aggregate formation is
crucial to the development of therapeutic strategies to
address AD.
In the process of Ab fibrillogenesis, both the initial and
final states of Ab peptide have been well characterized by
multiple biophysical methods (8,9,14). Molecular level 3D
structural models of Ab fibrils have been proposed indepen-
dently by several research investigators that agreed in the
fundamental parallel, in-register, cross-b assembly pattern
(15–17). Conversely, the intermediate oligomers, which are
increasingly thought to be the most toxic species in AD,
are much less understood because of their transient, hetero-
geneous nature. Although classifications may vary, three
distinct groups of Ab aggregation intermediates have been
identified before (7,18). Among them, low molecular weight
(LMW) oligomers consist of a narrow distribution of dimers
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to be equilibrated rapidly with Ab monomer in freshly
prepared samples (18,19). High molecular weight (HMW)
oligomers generally refer to larger Ab aggregates showing
a 9–25 nm diameter spherical or disc-like morphology
(8,10,13,20). Ab protofibrils are defined as the smallest
unit of mature fibrils, exhibiting Congo Red and thioflavin
T (ThT) binding, and ordered b-sheet structure (21–23).
However, a detailed molecular level structure difference
between intermediate Ab oligomers and maturely developed
fibrils has not been identified. Consequently, the molecular
basis for the observed structure-dependent neurotoxicity of
Ab aggregates are likewise unclear (10,24).
We have reported previously that multiple aggregated
Ab(1–40) species can be distinguished by their degree of
solvent accessibility using hydrogen exchange mass spec-
trometry (HX-MS) without proteolysis (25). Separate peaks
in HX mass spectra were assigned to a particular aggregated
species using multiple techniques, including size exclusion
chromatography (SEC), electron microscopy (EM), and
atomic force microscopy (AFM) as described previously
(13,25). We elucidate the local structural differences of
Ab(1-40) peptide formed in four increasingly aggregated
states by comparing their peptide level solvent accessibility
patterns measured by HX-MS. Due to the use of two
different immobilized enzyme columns (pepsin and type
XIII fungal protease in tandem), we increased the number
of Ab cleavage sites, thus the number of available reporter
peptides, which enabled the analysis of solvent accessibility
at enhanced spatial resolution (26). Most importantly, two
sets of intermediate Ab oligomers (i.e., LMW and HMW
oligomers) were examined for the first time by this approach
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were distinguished structurally from the well-developed
fibrils by their solvent accessibility patterns. We believe
these results help to provide new insight in the structural
basis for the distinct neurotoxicity associated with different
aggregated forms of Ab (13).
MATERIALS AND METHODS
Materials
Ab(1-40) was obtained from AnaSpec (San Jose, CA) as vials of 1.0-mg
lyophilized powder. Deuterium oxide (D2O) was obtained from Cambridge
Isotope Laboratories (99.9% Deuterium; Andover, MA). Pepsin from
porcine gastric mucosa and type XIII fungal protease from Aspergillus saitoi
were obtained from Sigma-Aldrich (St. Louis, MO). All other chemicals
were purchased from Sigma unless otherwise specified.
Sample preparation
All the Ab(1-40) samples were prepared in the same way as our previous
HX-MS study of intact Ab without proteolytic fragmentation (25). Briefly,
fresh Ab samples were made by mixing 4.3 mL stock solution (10 mg/mL in
0.1% trifluoroacetic acid (TFA; Fluka, Ronkonkoma, NY) solution) with
95.7 mL PBS buffer (10 mM NaH2PO4, 150 mM NaCl, pH 7.4) to a peptide
concentration of 100 mM. Aged Ab samples were prepared by quiescently
incubating the same diluted Ab solution (100 mM in PBS buffer) at 37 5
0.5C for desired times; we studied 4-h, 72-h, and 6-day aged samples
mainly. To ensure the pattern of aggregation was reproducible, the same
lot of Ab was used for all experiments.
Deuterium labeling
Basically, the same procedure (25) was used for the deuterium labeling of
most Ab samples by directly mixing 5 mL Ab solution with 45 mL D2O
in 1.5 ml Eppendorf centrifuge tube, giving a 90% deuterium (molar frac-
tion) in the labeling solvent. However, the 6-day aged sample was treated
somewhat differently before labeling. it was washed once to produce a rela-
tively pure fibril sample by centrifugation at 13,000  g for 10 min. Ninety
microliters of supernatant was removed and replaced by the same volume of
D2O to initiate the deuterium labeling. Thirty seconds of rigorous vortexing
was applied to resuspend fibrils. All the hydrogen-deuterium (H/D)
exchange reactions were carried out at pH 7.0 (as read with deuterium
present) and room temperature. The labeling times were chosen based on
the dynamic stability of analyzed Ab samples, and are specified in Results.
After labeling for the desired times, Ab aggregates were dissociated back
into monomeric state for mass spectrometer detection under conditions
where the H/D exchange was quenched. To increase the signal/noise ratio
(S/N) in acquired mass spectra, fresh, and aged Ab samples were processed
differently after the labeling step. For the fresh sample, H/D exchange reac-
tion was quenched by adding 30 mL mixture of dimethyl sulfoxide and
dichloroacetic acid (Fluka) (v/v, 95:5) to the 50 mL labeling solution to
decrease pH to 3.0 (as read). For the aged samples, large Ab aggregates
(mainly HMW oligomers and fibrils) were concentrated by centrifugation
at 13,000  g for 10 min. After removal of the supernatant, 30 mL dimethyl
sulfoxide/dichloroacetic acid mixtures were added. The effect of centrifuga-
tion operation on deuterium labeling for aged samples was shown to be
negligible by comparing the labeling results of reporter peptide 20-34 (the
one with highest S/N ratio, data not shown) without centrifugation step.
Enzyme digestion and HPLC procedures
The H/D exchange quenched samples were diluted to a low organic solvent
concentration by adding 420 mL 0.05% formic acid (FA) in D2O/H2OBiophysical Journal 96(3) 1091–1104mixture (90:10, molar ratio). The pH was maintained around 2.7 (as read).
The diluted sample was immediately injected into a 200 mL stainless steel
sample loop and then delivered through two immobilized enzyme columns
(pepsin and fungal protease type XIII in tandem) to the C18 small molecule
trapping column (1 mm ID  8 mm, catalog No. TR1/25108/01; Michrom
Bioresources, Auburn, CA). An isocratic stream of 5% acetonitrile (ACN)
and 0.1% FA in distilled, deionized water (H2O) was used. The flow rate
was 200 mL/min. To prepare the pepsin and fungal protease type XIII
columns, immobilized enzyme beads (POROS-20AL; Applied Biosystems,
Sunnyvale, CA) were prepared and packed into column (2.1 mm ID 
30 mm, catalog No. 2-3008-05; Applied Biosystems) according to the manu-
facturer’s instructions. A bed volume of ~100 mL led to ~30 s of digestion
time in each enzyme column. The digested peptide mixture was desalted
for 3 min, and then eluted from the trapping column using a gradient of
ACN fraction from 5% to 50% over 5 min at flow rate of 50 mL/min. The
two composite solvents were 0.1% FA and 0.01% TFA in ddH2O
(solvent A) and 0.2% FA in ACN (solvent B). The eluted peptide mixture
was sent to mass spectrometer for analysis. To minimize artifactual
exchange during the analysis time, all the columns, loops, and lines were
immersed in ice bath during all the experiments.
Mass spectrometry
Mass spectra were acquired by a linear ion trap mass spectrometer with
a standard electrospray ionization source (LTQ, Thermo Electron Corpora-
tion, San Jose, CA) at scanning mode of positive polarity, zoom scan, and
selected ion monitoring. Eight discrete m/z ranges were specified to simulta-
neously detect the eight proteolytic reporter peptides during each run. Other
acquisition parameters were set as follows: capillary temperature: 250C,
spray voltage: 4.3 kV, sheath gas flow: 40 unit, capillary voltage: 15 V;
tube lens voltage: 105 V.
Spectral deconvolution and artifactual exchange
correction
The mass spectra were analyzed as described before (25). Briefly, for HX-
MS spectra containing a single peak, the centroid mass was used to deter-
mine the average mass for labeled reporter peptides. Spectra with multiple
peaks (bimodal at most in this study) were fit with two Gaussian peaks using
Microsoft Excel.
Both forward and back exchange occurring during the sample analysis
time were taken into account for all the reporter peptides using the method
developed by Wetzel et al. (27):
corrected deuterium incorporation :
Dcoor¼ mMW þ BE FE; ð1Þ
forward exchange : FE ¼ m0 MW; (2)and
back exchange : BE ¼ MW þ N  m100: (3)
All the parameters in the equations above have definitions identical the
those cited by Kheterpal et al. (27), and the only difference is that they
are applied to proteolytic peptides, rather than intact Ab protein. MW is
the theoretic mass of each reporter peptide, measured from unlabeled
Ab(1-40) sample with the final dilution step incorporating 0.05% FA in
H2O instead of D2O/H2O mixture. m0 is the measured average mass of unla-
beled sample using D2O-rich solvent dilution described in Materials and
Methods. m100 is the average mass of peptide from fully labeled Ab(1-40)
sample by dissolving Ab in D2O-based PBS for 1 h at room temperature.
m is the average mass from test samples after certain labeling times. N repre-
sents the total exchangeable backbone amide protons within each reporter
peptide. To account for the 90% Deuterium under our labeling condition,
modification to Eq. 1 was made (see below):
Ab(1-40) Structure by HX-MS 1093Dcoor ¼ ðmMW þ BE FEÞ=0:9: (4)
The fractional deuteration or solvent accessibility (SA) of each reporter
peptide was then defined by
SA ¼ Dcoor
N
 100%: (5)
Circular dichroism spectroscopy
All the circular dichroism spectroscopy (CD) measurements were carried out
on an Aviv CD spectrometer (Model 215; AVIV Biomedical, Lakewood,
NJ) at 25 5 0.5C. The path length of the quartz cell is 0.5 mm. The
scanning wavelength was 195–260 nm with step size of 1 nm. For each
sample, three scans were acquired and averaged. All the presented spectra
were corrected by subtracting the baseline spectrum collected for PBS
buffer.
Congo Red binding assay
Congo Red (CR) solution (120 mM in PBS buffer) was filtered through
0.22 mm syringe-driven filter three times before use, and then mixed with
100 mM Ab(1-40) sample in a 96-well plate at a volume ratio of 1:9 (CR
vs. Ab solution). After binding for 45 min at room temperature, absorbance
at two wavelengths of 405 nm and 540 nm was measured by SpectraMax
Plus384 Microplate Reader (Molecular Devices, Sunnyvale, CA). PBS buffer
was used as the blank reference. The concentration of Congo Red (mol/L)
bound to Ab sample was determined by Klunk et al. (28).

CR Ab ¼ A541t =47; 800  A403t =68; 300  A403CR =86; 200
(6)
A403t and A
541
t are the total absorbance of Ab(1-40) plus Congo Red at
405 nm and 540 nm, respectively. A403CR is the absorbance of Congo Red
alone in PBS at 403 nm. Absorbance values at 405 nm and 540 nm were
assumed to be same as those at 403 nm and 541 nm (28).
RESULTS
The assignment of HX labeling behaviors
to particular aggregated species
We have reported previously that multiple aggregated Ab
(1-40) species can be distinguished by their degree of solvent
accessibility using HX-MS without proteolysis (25). Sepa-
rate peaks in HX mass spectra were assigned to a particular
aggregated species using multiple techniques, including
SEC, EM, and AFM as described previously (13,25). Briefly,
the bimodal labeling pattern of fresh Ab(1-40) sample was
correlated with the two species of monomer (fully labeled
peak) and LMW oligomers (partially labeled peak) thatwere shown in SEC experiments in similar proportions
(13). For Ab samples aged 4 h and 10 h, one predominant
peak with moderate solvent accessibility was observed in
HX mass spectra, whereas EM and AFM showed the
primary HMW oligomer species to be spherical or disk-
like (13,25, and Fig. S3 in the Supporting Material). For
6-day aged, washed fibrils, HX spectra yielded a homoge-
neous peak with a low degree of deuterium labeling.
Although aged Ab samples are certainly heterogeneous in
general, the above conditions yielded predominantly one
aggregated species, allowing the assignment of HX behavior
for at least the predominant oligomer morphologies listed
above.
In the current study, the peptide level solvent accessibility
patterns were investigated via enzymatic digestion to show
the local structural differences between various aggregated
species. To allow comparison with our previous experi-
ments, all the samples were prepared, aged, and labeled
with deuterium with the same procedures as our previous
study.
Ab(1-40) proteolysis efﬁciency and artifactual
exchange
Online proteolysis of Ab(1-40) peptide was carried out with
two immobilized acid-compatible enzyme columns operated
in tandem, one containing pepsin and the other containing
fungal protease type XIII. As shown in Fig. 1, the use of
two enzymes with different cleavage preferences provided
us with more reporter peptides detectable in the mass spec-
trum with a high S/N ratio than was reported previously
for Ab (26). The assignments of all the eight reporter
peptides were confirmed by running MS/MS mass spectrom-
etry and analyzing the obtained spectra with software Turbo-
SEQUEST. Met35 in Ab(1-40) was not oxidized after our
sample preparation as indicated by the absence of an
oxidized peak for intact Ab and reporter peptide 35–40 in
our mass spectra (data not shown). As another significant
evaluation of our experimental system, both forward and
back exchange induced into each reporter peptide during
the sample processing time were determined by a series of
control experiments as described in Materials and Methods.
These control experiments were essential for the precise
assessment of the peptide level solvent accessibility for
different Ab(1-40) samples. In our system, the measured
back exchange of eight reporter peptides varied betweenFIGURE 1 Eight reporter peptides from Ab(1-40)
protein observed in HX-MS spectra using sequential im-
mobilized pepsin and fungal protease type XIII enzyme
columns. All the peptides were identified according to their
mass and charge states and further confirmed by MS/MS.Biophysical Journal 96(3) 1091–1104
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and 1-19 showing a significantly higher degree of back
exchange (38.8% and 42.6%, respectively), and the six
C-terminal peptides having a degree of ~30.0% or below.
In contrast, the forward exchange was low and relatively
constant for all the reporter peptides (0.2%–5.4%).
Solvent accessibility of washed Ab(1-40) ﬁbrils
at proteolytic peptide level
The solvent accessibility of Ab fibrils has been well investi-
gated at different resolution level by several research groups
(25,26,29,30). The re-examination of Ab(1-40) fibrils here
was used to validate our experimental protocol and data
analysis by comparing our measurements with two previous
independent studies (Supporting Material). In this study,
6-day aged washed Ab samples were treated as pure fibrils
(see preparation in Materials and Methods), which was
supported by the observed highly homogeneous labeling
distribution in obtained HX-MS spectra both by earlier study
of intact Ab (25) and this peptide level investigation. The
representative HX-MS spectra of eight reporter peptides
from washed fibrils after 24 h deuterium labeling are shown
in the Supporting Material. Deuterium labeling into each
proteolytic reporter peptide of fibrils (shown in the fibril
column of Table 1) was calculated from centroid mass of
HX-MS spectra as described in Materials and Methods.
Consistent data of solvent accessibility was found for
Ab(1-40) fibrils either between this and two previous studies
or between this and our earlier study (Supporting Material),
validating the methodology used.
The general solvent accessibility pattern of washed Ab
(1-40) fibrils is indicated by the deuterium labeling of three
nonoverlapping reporter peptides spanning the whole
sequence, e.g., reporter peptides 1-19, 20-34, and 35-40 in
TABLE 1 Summary of measured deuterium number
incorporated into each Ab reporter peptide from different
aggregated states
Fragment
Total
exchangeable
protons
Corrected deuterium number
Monomer* LMW* HMWy Fibrilz
1-16 15 15.25 0.4 15.25 0.4 14.75 0.3 8.25 0.3
1-19 18 18.05 0.4 18.05 0.4 15.65 0.4 8.85 0.3
20-33 13 12.85 0.3 7.7 5 0.3 5.75 0.2 5.25 0.1
20-34 14 13.95 0.3 8.6 5 0.3 5.95 0.3 5.55 0.1
23-34 11 10.85 0.3 7.8 5 0.4 5.75 0.2 5.45 0.3
34-40 6 5.75 0.1x 4.0 5 0.1{ 3.95 0.1 3.95 0.1
35-40 5 4.85 0.1x 3.7 5 0.1{ 3.65 0.1 3.75 0.1
20-40 19 19.95 0.2 11.85 0.4 8.95 0.3 8.65 0.3
Uncertainties are based on the SD triplicates.
*Ab(1-40) monomer and LMW oligomers from fresh sample, labeled
for 10 s.
ySpherical HMW oligomers from 4-h aged samples, labeled for 1 h.
zWashed fibrils from 6-day aged sample, labeled for 24 h.
xValues determined from 1 h labeled fresh sample.
{Value determined from calculation by Eq. 7.Biophysical Journal 96(3) 1091–1104Table 1. The two terminal regions 1-16 (54.7 5 2.0%
deuteration calculated based on Table 1) and 35-40
(74.0 5 2.0%) showed a higher degree of solvent accessi-
bility than the central b-structure forming fragment 20-34
(39.3 5 1.0%) in fibril assembly (31,32). A more detailed
pattern of solvent accessibility for Ab fibrils was also avail-
able through the analysis of labeling differences between
partially overlapping reporter peptide pairs. For instance,
given the deuterium numbers of 8.2 5 0.3 and 8.8 5 0.3
measured for reporter peptides 1-16 and 1-19 respectively,
the labeling difference of 0.6 5 0.4 is indicated to arise
from residues 17-19, meaning a solvent accessibility
of ~20.0 5 13.3% in this segment. Likewise, the nearly
identical deuterium labeling of reporter peptides 20-34 and
23-34 (5.5 5 0.1 vs. 5.4 5 0.1) suggests that residues
21–23 are almost fully protected from H/D exchange.
However, the labeling status of residue 20 could not be deter-
mined based on the above two reporter peptides alone,
because the N-terminal residue is no longer an amide and
exchanges rapidly with solvent H2O during analysis. Table 2
(Fibril column) shows the deuterium labeling of subpeptides
or particular residues for washed fibril sample determined
from all the peptide pair comparison.
Solvent accessibility of Ab(1-40) monomer
and LMW oligomers at proteolytic peptide level
The freshly prepared sample of Ab(1-40) peptide was shown
to be a mixture of fully solvent exposed monomer and
partially protected LMW oligomers by our earlier HX-MS
study (25). The left column of Fig. 2 (reproduced from Qi
et al. (25) by permission) shows the HX-MS spectra of undi-
gested fresh Ab(1-40) sample after three different labeling
times. The bimodal HX behavior observed with labeling
TABLE 2 Summary of deuterium number incorporated into Ab
subpeptides or residues from different aggregated states
Residue(s)
Total
exchangeable
protons
Deuterium incorporation
Monomer* LMW* HMWy Fibrilz
1–16x 15 15.25 0.4 15.25 0.4 14.75 0.3 8.25 0.3
17–19{ 3 2.85 0.6 2.85 0.6 0.9 5 0.5 0.65 0.4
21–23{ 3 3.15 0.4 0.85 0.5 0.2 5 0.4 0.15 0.3
24–33k 10 9.75 0.5 6.95 0.6 5.5 5 0.4 5.15 0.3
34{ 1 1.15 0.4 0.95 0.4 0.2 5 0.4 0.35 0.1
35{ 1 0.95 0.1 0.35 0.1 0.3 5 0.1 0.25 0.1
36–40x 5 4.85 0.1 3.75 0.1 3.6 5 0.1 3.75 0.1
Uncertainties are calculated by error propagation.
*Ab(1-40) monomer and LMW oligomers from fresh sample, labeled
for 10 s.
ySpherical HMW oligomers from 4-h aged samples, labeled for 1 h.
zWashed fibrils from 6-day aged sample, labeled for 24 h.
xValues are determined from direct measurement of reporter peptides 1-16
and 35-40, respectively.
{Values are determined from labeling difference between partially overlap-
ping peptide pairs.
kValue is determined by subtracting the deuterium number of residues 21–23
from reporter peptide 20-33.
Ab(1-40) Structure by HX-MS 1095FIGURE 2 Representative HX-MS spectra of intact Ab(1-40) (left), and two reporter peptides 1-19 (middle) and 20-40 (right) from freshly prepared sample.
The labeling time for each sample is marked on the left side of each row of spectra as 10 sec, 10 min and 1 h. The assignments of peaks are marked with L
(LMW oligomers) and M (monomer). Intact Ab(1-40) spectra are reproduced from Qi et al. (25) by permission.times indicate the presence of two labeling states with
distinct solvent accessibility, consistent with the observa-
tions by SEC and native PAGE of two species in dynamic
equilibrium, monomer and LMW oligomers primarily
composed of dimer (13,29). Moreover, the molar ratio of
two labeling states shown by a short H/D exchange time
(10 s) agreed with the monomer/dimer ratio of ~1:1 by
SEC (13). Therefore, the two peaks in Fig. 2, a and b, are
assigned to be fully labeled monomer (high mass peak)
and protected LMW oligomers (low mass peak).
To identify the protected region of Ab peptide in the early
formed LMW oligomers, the postlabeled fresh sample was
subject to proteolytic cleavage, and the digested peptide
mixture was analyzed instead of intact Ab to determine
solvent accessibility patterns. Representative HX-MS
spectra of two complementary reporter peptides 1-19 and
20-40 after 10 s, 10 min, and 1 h labeling are shown in the
right two columns of Fig. 2. Interestingly, reporter peptide
1-19 displays one single peak in mass spectra at all the
labeling times. The calculated deuterium labeling after arti-
factual exchange correction is 18.05 0.4 (Table 1), equiv-
alent to the maximum value achievable at full deuteration
situation of this peptide. This indicates that the N-terminalregion spanning residues 1–19 of Ab(1-40) peptide is flex-
ible and rapidly solvent exposed in both the monomeric
and LMW forms found in fresh samples. Similar spectra
were observed for reporter peptide 1-16 (data not shown).
In contrast, reporter peptide 20-40 shows an abundance tran-
sition between two labeling states with increasing labeling
times, similar to that observed in intact Ab(1-40), suggesting
that the protected region of Ab in LMW oligomers is located
in C-terminal half region 20-40. The two labeling states were
fitted by two Gaussian peaks and gave a corrected deuterium
number of 11.8 5 0.4 and 19.9 5 0.2 (full deuteration),
respectively (Table 1).
To further localize the residues showing HX protection in
LMW oligomer structure, the HX-MS spectra of two smaller
reporter peptides are shown in Fig. 3. Similarly, reporter
peptide 20-34 shows a bimodal HX behavior with varying
labeling times. The rate of decrease in the low mass peak
with labeling time is comparable with these observed for
intact Ab and reporter peptide 20-40 (Fig. 2). Similar spectra
were obtained for reporter peptides 20-33 and 23-34 (data
not shown). The deuterium labeling for the two peaks of
peptide 20-34 spectra (Fig. 3 a) is 8.6 5 0.3 and 13.9 5
0.3, respectively (Table 1). On the other hand, the HX-MSBiophysical Journal 96(3) 1091–1104
1096 Zhang et al.FIGURE 3 Representative HX-MS spectra of reporter
peptides 20-34 (left column) and 35-40 (right column)
from freshly dissolved Ab(1-40) sample. The labeling
time for each sample is marked on the left side of each
row of spectra as 10 s, 10 min, and 1 h.spectra of reporter peptide 35-40 seem to be unimodal.
However, the calculated centroid mass was found to increase
with the labeling time, suggesting the presence of a partially
labeled species together with the fully labeled peptide. This
is also consistent with a less degree of protection observed
for reporter peptide 20-34 (5.3 5 0.4 unlabeled residues)
relative to reporter peptide 20-40 (8.15 0.4 unlabeled resi-
dues). Therefore, the residues protected from H/D exchange
in LMW oligomers are distributed throughout the C-terminal
half region spanning sequence 20-40.
Notably, the HX protection observed for either intact Ab
molecule and digested peptides from LMW oligomers had
a limited lifetime. In Figs. 2 and 3, the less labeled peaks
disappear almost completely after 1 h of labeling both.
This suggests that the structure within LMW oligomers
causing the solvent protection is not stable for timescales
longer than 1 h, either because of rapid association/dissocia-
tion equilibrium with fully unfolded monomeric state or
large-scale fluctuation in structure sufficient to become
solvent exposed in region 20-40.
Because of the low resolution of the protected and unpro-
tected species in reporter peptide 35-40 (Fig. 3 b), the deute-
rium labeling of the less labeled component was calculated in
another way as described previously (26). The centroid massBiophysical Journal 96(3) 1091–1104of the entire spectrum is a weighted sum of the partially
labeled and fully labeled contributions:
Mave ¼ a1MPL þ a2MFL: (7)
Where Mave, MPL, and MFL are the centroid mass of the over-
all isotopic peak distribution, the partially labeled compo-
nent of LMW oligomers and the fully labeled component
of monomer, respectively. a1 and a2 are the relative abun-
dances of two differently labeled species in a short labeling
time, i.e., Ab LMW oligomers and monomer fractions in
fresh sample.
In Eq. 7, Mave ¼ 563.9 5 0.1 was calculated from the
10 s-labeling spectrum of reporter peptide 35-40 (Fig. 3 b).
MFL ¼ 564.5 5 0.1 was determined from the spectrum of
reporter peptide 35-40 after 1 h labeling (Fig. 3 f), by which
time we assumed that LMW oligomer became fully labeled
as indicated by the intact Ab and reporter peptide 20-34
spectra (Fig. 2). The relative abundance a1 ¼ 0.65 5 0.03
and a2 ¼ 0.355 0.03 were determined from the deconvolu-
tion of the better resolved spectrum of reporter peptide 20-34
(Fig. 3 a). With these values, a centroid mass of 563.65 0.1
for the partially labeled component was determined,
corresponding to a deuterium labeling of 3.7 5 0.1 after
Ab(1-40) Structure by HX-MS 1097correction for reporter peptide 35-40. The same analysis was
carried out to gain the deuterium labeling value for reporter
peptide 34-40 shown in Table 1.
Solvent accessibility of HMW oligomers
at proteolytic peptide level
Like LMW oligomers observed in fresh Ab samples, HMW
oligomers exist in mixtures together with other Ab species
and cannot be completely isolated. Consequently, we focused
on aging conditions that provided a predominant fraction of
these oligomers and used HX-MS to distinguish these oligo-
mers from the other species. Our earlier studies of intact Ab
(1-40) by AFM and EM showed that HMW oligomers became
the predominant species in 4–10 h aged samples and coexisted
with mature fibrils in 72 h aged samples (13,25). These
microscopy results allowed peaks in HX-MS spectra of intact
Ab (Fig. 4, left column; reproduced from Qi et al. (25) by
permission) to be assigned. Three distinct peaks wereobserved to transform in their abundance with respect to the
aging time, while keeping the individual m/z unchanged.
The peak with the lowest m/z (~1084.8) was the highly pro-
tected Ab fibrillar species mainly found in the 6-day washed
sample (Fig. 4 i) and 72-h aged sample (Fig. 4 e). The minor,
high mass peak appearing in 4-h and 72-h samples had
a centroid position of ~1090.4, consistent with a monomeric
state with full deuteration. Finally, the peak with an interme-
diate m/z (~1087.1) was assigned to HMW oligomers accord-
ing to their relative abundance in the 4-h and 72-h aged
samples observed in AFM images (25).
The discrimination of different aged samples by intact Ab
HX-MS discussed above facilitated the analysis of solvent
accessibility at the proteolytic peptide level. However, it
should be noted that as described in Materials and Methods,
all the aged samples were subjected to centrifugation to
concentrate the large Ab aggregates for peptide level analysis
and meanwhile reduce the contribution of LMW oligomersFIGURE 4 Representative HX-MS spectra of different aged Ab samples after 1 h deuterium labeling. Each row represents one sample aging time denoted at
left. Each column presents one report peptide denoted on the top. The assignments of peaks to different species are marked as F (fibrils), H (HMW oligomers),
and M (monomer).The intact Ab spectra in the left column are reproduced from Qi et al. (25) by permission.Biophysical Journal 96(3) 1091–1104
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of three selected reporter peptides (1-19, 20-34, and 35-40)
are also shown in Fig. 4. The simplest HX behavior was
observed for 6-day washed fibrils, which showed relatively
homogeneous labeling distributions for the three reporter
peptides (Fig. 4, j–l). Similarly, the reporter peptides from
4-h aged samples have predominantly one peak (Fig. 4, b–
d), consistent with the predominance of one peak due to
HMW oligomers in the intact spectrum (Fig. 4 a). Reporter
peptides 20-34 and 35-40 showed centroid peak positions
similar to those obtained for washed fibrils. The main cause
for the difference in labeling of intact HMW oligomers would
seem to be within reporter peptide 1-19, which was labeled to
a much higher degree in 4-h samples (Fig. 4 b) than
6-day washed fibrils (Fig. 4 j). The 72-h aged samples showed
very similar HX-MS spectra to the other two aged samples in
reporter peptides 20-34 and 35-40. However, two well
resolved peaks were observed for reporter peptide 1-19,
with the low mass peak having a close centroid position to
the single peak from 6-day washed fibrils, and the high
mass peak to the major peak from 4-h aged sample. The other
reporter peptides showed similar behavior as depicted in
Fig. 4, with peptide 1-16 being similar to 1-19; peptides 20-
40, 20-33, and 23-34 being similar to 20-34; and peptide
34-40 being similar to peptide 35-40. The number of deuteron
labeled in the reporter peptides of HMW oligomers were
calculated using the 4-h spectra (Table 1). As a consistency
check, the total deuterium number of three reporter peptides
1-19, 20-34, and 35-40 for HMW oligomers are
(25.1 5 0.5), slightly higher than the direct measurement
from our early intact Ab analysis (23.35 0.9) (25).
The HX-MS spectra of 4-h aged sample (Fig. 4, top row)
provide some additional insight regarding the structure of
Ab(1-40) HMW oligomers. Reporter peptide 20-34 shows
an asymmetric isotopic peak envelope with a high mass tail
having a deuterium labeling intermediate between LMW
and HMW oligomers. Similar mass spectra were also
observed for two other reporter peptides 20-35 and 20-40
(data not shown). The tails in HX-MS spectra associated
with C-terminal reporter peptides may indicate a heteroge-
neous distribution of solvent accessibility in this region for
HMW oligomers formed in 4-h aged sample. Taking into
account the significant variance in the size dimension of
HMW oligomers observed by AFM (25), a correlation
between the assembly size of HMW oligomers and the degree
of solvent protection might be present. For example, addition
of more Ab peptides into the oligomer structure could lead to
a more rigid or ordered assembly pattern, thus a higher extent
of solvent protection in the HMW oligomers.
Comparison of peptide level solvent accessibility
pattern for different Ab(1-40) aggregated states
The solvent accessibility pattern of Ab peptide in different
aggregated states can be compared between each other.
Fig. 5 (data based on Table 2) summarizes the peptide levelBiophysical Journal 96(3) 1091–1104HX results of four Ab aggregated forms: monomer, LMW
oligomers, HMW oligomers, and fibrils. The results are pre-
sented in two formats: 1), the solvent accessibility pattern
for each aggregated state is shown in Fig. 5 a), particular frag-
ments with significant difference in solvent accessibility
between two sequential aggregated states are identified in
Fig. 5 b. Due to the rapid exchange rates for the fresh Ab
samples and additional isolation steps used for the aged
samples, the solvent accessibility for different samples were
not compared at a common, short labeling time. This prevents
a precise quantitative comparison of residue numbers
showing HX protection under identical labeling and sample
workup conditions. However, the fact that all the reporter
peptides show a decreased degree of solvent accessibility
with the increasing aggregated states even though they are
subject to a longer labeling time means the actual differences
in degree of labeling are even more significant.
From Fig. 5 a, we can see that LMW oligomers experience
a reduction in solvent accessibility in the C-terminal region
21-40 as compared to the monomer sample. As LMW olig-
omers are converted to HMW oligomers, solvent accessi-
bility is further reduced in residues 21-34; the region of
protection is also extended to residues 17-19. However,
both LMW and HMW oligomers retain nearly full solvent
accessibility in the N-terminal region 1-16. This N-terminal
reporter peptide remains quite solvent exposed until the
development of fibrils, in which about half of its residues
become protected from H/D exchange. By comparing the
solvent accessibility patterns for the four states, Fig. 5 b high-
lights how solvent protection spreads from the C-terminus to
the N-terminus with increasingly aggregated states.
Secondary structure changes during Ab
aggregation
The secondary structure changes occurring during Ab aggre-
gation were examined by CD spectroscopy as shown in Fig. 6.
At diluted low peptide concentration (10 mM), where the
monomeric species was favored thermodynamically, Ab
adopted primarily random coil conformation (Fig. 6, curve 1).
In contrast, a shallow band around 210–220 nm was observed
for the elevated 100 mM fresh sample (Fig. 6, curve 2), where
we have already shown a substantial fraction of oligomeric
species were formed (13,25). After incubation of various
times, all the aged samples (100 mM) display far stronger
characteristic absorbance of b-sheet structure around 215–
220 nm, with a continuous increase in the signal at 218 nm
[q]218 over aging time. Light scattering caused by large Ab
aggregates in aged samples could be considered to be a poten-
tial influence on these results. However, these effects should
not be significant in our study because the CD signal was
not distorted obviously by existing scattering noise. The
fibril-containing samples (Fig. 6, curves 5 and 6) remained
a major b-structure characteristic absorbance as smaller olig-
omeric samples with intermediate aggregation. Moreover, the
dynode voltage was far below 500 V for all samples,
Ab(1-40) Structure by HX-MS 1099FIGURE 5 Presentation of peptide
level solvent accessibility for Ab(1-
40). (a) The peptide level solvent acces-
sibility pattern of Ab(1-40) in different
aggregated states. The deuterium
labeling times for monomer (light
gray) and LMW oligomers (gray)
from fresh sample, HMW oligomers
(dark gray) from 4-h aged sample, and
fibrils (squared) from 6-day washed
sample are 10 s, 1 h, and 24 h, respec-
tively. The horizontal dash dot line
corresponds to 100% solvent accessi-
bility at full deuteration. (b) Ab reporter
regions with significant difference in
solvent accessibility between two
sequential aggregated states. Bars span
peptide regions that are significantly
different (significance level a is 0.05)
for three pairwise comparisons:
(LMW-MON) LMW oligomers versus
monomer, (HMW-LMW) HMW versus
LMW oligomers, and (FIB-HMW)
fibrils versus HMW oligomers. No
bars are shown for regions without
significant differences.indicating a consistently low degree of contribution from scat-
tering noise. Thus, although light scattering effects might still
affect a quantitative deconvolution to determine small
changes in secondary structure content, they should not affect
the qualitative conclusion that b structure is increasing with
aging time. Given the relatively constant abundance of mono-
meric Ab in all the aged samples (25), the growth of the b-
sheet content may reflect the extension of b-strands in Ab
peptide when the mature fibril structure develops from
HMW oligomers.
Congo Red is a histological dye usually used to monitor the
growth of amyloid fibrils. However, some forms of Ab inter-
mediates were also found to show a binding capacity (34). In
this study, the amount of Congo Red bound to different Ab
samples was measured as an indicator of the ordered cross-
b structure present in the formed predominant aggregated
states. As expected, Fig. 7 shows the fresh sample has a low
Congo Red binding capacity, indicating the lack of ordered
cross-b structure in both Ab monomer and LMW oligomers.
For the samples of short aging times (1 and 2 h), a gradual
increase in CR binding was observed. Samples aged for 4 h
and 10 h, in which HMW oligomers become the dominant
species, reached a plateau of Congo Red binding. Thereafter,no significant change was observed for even longer aged
samples, though the amount of fibrillar species grew substan-
tially in 72-h and 6-day aged samples. This result suggests that
Congo Red is not able to distinguish the intermediate HMW
oligomers and maturely developed amyloid fibrils.
DISCUSSION
The understanding of Ab aggregation at molecular level is
central to the development of therapeutic strategies to
address Alzheimer’s disease. To date, considerable efforts
have been exerted to investigate the aggregation process
(4,8,34). However, most previous studies were concentrated
on either the late fibril growth phase or the large, and dynam-
ically stable Ab aggregates such as protofibrils and fibrils
(17,26,34), whereas the structure of the earlier oligomers
are much less explored. For example, HX-MS has been
applied to study Ab aggregates, but only to fibrils (29,35)
and chemically stabilized protofibrils (26,36). HX detected
by NMR has been applied only to fibrils as well (30). We
report the local solvent accessibility of two intermediate
oligomers (LMW and HMW oligomers) along with the
monomeric and fibrillar Ab, using HX-MS with proteolyticBiophysical Journal 96(3) 1091–1104
1100 Zhang et al.digestion to increase spatial resolution. Although the anal-
ysis of HX kinetics is not as quantitative as has been
applied to HX-NMR studies of nonaggregating proteins,
mass spectrometry detection facilitates the resolution and
analysis of oligomeric species present in mixtures. This is
an important issue for distinguishing the structural features
of transient Ab oligomers.
The Ab(1-40) subpopulation distribution with respect to
aging time shown by HX-MS and AFM in our previous
study (25) indicated a progressive aggregation pathway
started with unfolded monomer and ended with mature fibrils
with two intermediate oligomeric species. In this aggregation
process, the initial self-association occurs readily on sample
dissolution, leading to the formation of LMW oligomers in
rather rapid equilibrium with monomer (8,13). During the
subsequent oligomer growth phase, Ab oligomers grow in
assembly sizes and coincide with a gradual increase in
structure stability indicated by HX-MS (25). Though
a further detailed discussion of the aggregation mechanism
and kinetics is beyond our scope, the peptide level HX-MS
analysis can show the local changes in solvent accessibility
that accompanies formation of each species.
Introduction of solvent protected b-sheet
structure into the C-terminal region 20-40
during the early oligomerization process
The Ab peptide is generally considered to be fully unfolded
in the monomeric state in aqueous solution (37,38). Our HX
FIGURE 6 The Ab(1-40) secondary structure changes during aggregation
shwon by CD. The investigated samples are: fresh sample 10 mM (curve 1),
fresh sample 100 mM (curve 2), 4-h aged sample (curve 3), 10-h aged sample
(curve 4), 72-h aged sample (curve 5), and 6-day aged sample (curve 6). All
the aged samples were measured at concentration 100 mM.Biophysical Journal 96(3) 1091–1104data experimentally confirmed that a significant portion of
monomeric Ab(1-40) in fresh sample was fully solvent
accessible within the shortest (10 s) labeling time (Fig. 2).
Under our aggregation conditions, however, we also
observed a comparable fraction of oligomeric Ab in freshly
prepared sample exhibiting solvent protection in reporter
peptides 20-34 and 35-40 (Fig. 3). According to the CD
spectra of fresh Ab samples under two concentration condi-
tions (Fig. 6), b-sheet structure is introduced into the early
formed LMW oligomers to some extent when the randomly
coiled Ab monomers are associated together. Thus, one
source for the H/D exchange protection in LMW oligomers
could be attributed to the b-sheet structure contact between
Ab peptides. Because the N-terminal region 1-19 remains
the full solvent accessibility in oligomeric structure, the
b-sheet structure contact in LMW oligomers is most likely
located in the hydrophobic C-terminal region of Ab peptide.
In particular, residues 21–23, 35, and part of fragments
24–33 and 36–40, all showing significant solvent protection
(Fig. 5 a), are probably the early residues involved in the
initiation of b-strands in Ab peptide. These residues
distribute throughout sequence 20-40, raising the possibility
that the two b-strands present in the structural model of
mature Ab(1-40) fibrils (strands at residues 12-24 and
30-40, respectively according to Tycko et al. (31)) are formed
in a partially concerted and not purely sequential manner.
FIGURE 7 Congo Red binding changes with Ab(1-40) sample aging
time. The error bar was calculated from measurements on triplicates. Desig-
nations above each bar indicate the type of Ab(1-40) aggregates present in
sample, as indicated by complementary AFM and EM studies under the
same conditions and the intact HX-MS labeling (13,25).
Ab(1-40) Structure by HX-MS 1101Interestingly, Fig. 5 indicates that residues 21–23 and 35
are among the first residues undergoing large reductions in
solvent accessibility in the early formed LMW oligomers.
This is a bit surprising given that adjacent residues (e.g.,
17–20, 24, 31–34, and 36–40) are more hydrophobic. These
residues include the central hydrophobic core 17-21 of partic-
ular significance in Ab fibril formation (32,39–41). Why
might this be the case? First, it should be noted that Fig. 5
shows solvent accessibility averaged over reporter peptides.
Peptide 24-33 shows a smaller average reduction in solvent
accessibility (~30%), but this could involve a short stretch
of concentrated, reduced solvent exposure near 21-23 or 35.
There are other reasons to believe that residues 21–30
might be more important than residues 17–20 early in the
oligomerization process. Limited proteolysis experiments
show residues 21–30 are less solvent exposed than residues
17–20 (42) consistent with our observations. Meanwhile,
there are studies pointing to a new notion that the formation
of b-turn structure in region 21-30 nucleates the folding
process of Ab monomer, and initiates the molecular associ-
ation to LMW oligomers (43,44). In this view, the electro-
static interaction between Lys28 and Glu22/Asp23 are crucial
in stabilizing the early compact molecule structure. If such an
interaction is occurring in an intermolecular manner as in the
final fibril structure, i.e., the residues Lys28 and Glu22/Asp23
forming salt bridges are from two different Ab molecules
(16,31), these charged residues would also play a significant
role in facilitating the fast oligomerization process in the
early stage. Therefore, the solvent protection for residue
21–23 in our observation could be a result of this initial
folding and association process mainly occurring in region
21-30. The hydrophobic core residues 17–20 may show
more importance in the late aggregation stage by forming
in-register cross-b structure, leading to complete loss of
solvent accessibility in these residues in large aggregated
forms such as HMW oligomers and fibrils described below.
Development of ﬁbril-like ordered b-sheet
structure within residues 17–34 during
oligomer growth phase
HMW oligomers dominant in the 4–10 h aged samples
showed a significant shift to the elevated b-sheet content
(Fig. 6) and Congo Red binding (Fig. 7) relative to LMW
oligomers in the freshly dissolved sample. These two
measurements indicate a more ordered and extended b-sheet
assembly in the growing oligomeric structure. In the parallel
HX analysis, a significant reduction in solvent accessibility
was only observed within region 17-34 (Fig. 5 b), the major
portion of b-strand forming region in Ab(1-40) peptide
(31,32). These results suggest that the local b-structural
development in region 17-34 may characterize the structure
change during oligomer growth stage. In fact, Ab molecules
constructing HMW oligomers showed an indistinguishable
solvent accessibility pattern from these in fibrillar structurein the C-terminal region 17-40 (Fig. 5 b), strongly indicating
the development of fibril-like assembly features in 4–10 aged
HMW oligomers. The structural similarity between large
spherical oligomers and mature fibrils in the C terminus
has also been suggested by one early solid state NMR study
of captured intermediate Ab(1-40) oligomers (45). From
LMW oligomers to HMW oligomers, the trend toward
more ordered assembly of Ab peptides within oligomer
structure as it grows has been suggested by multiple molec-
ular simulation studies of variant Ab subpeptides (46–48),
though direct experimental evidence is still lacking. The
change in the peptide assembly pattern in oligomer structures
can lead to the observed distinct structural stabilities for
LMW oligomers and HMW oligomers. HMW oligomers
seem to have a lower rate in molecular dissociation or
large-scale structure fluctuation compared to LMW oligo-
mers as evidenced by the preserved solvent protection after
1 h exchange (Figs. 2 and 4).
Extension of solvent exclusive b-sheet structure
into the N-terminal region 1-16 on ﬁbril formation
The structure of Ab(1-40) fibrils have been studied exten-
sively by assessment of HX solvent accessibility at different
resolution levels from multiple research groups (25,26,30).
Consistent results were obtained in this study (Supporting
Material), indicating that the slightly different sample prepa-
ration protocols result in largely equivalent fibrils. In addi-
tion, relatively good agreement was also found between
our solvent accessibility profile of washed fibrils (Fig. 5 A)
and the 3D structural model proposed by Tycko et al. (31)
based on solid state NMR data. The residue numbers with
deuterium labeling within peptide 1-16 and 23-34 agree
with the lengths of disordered N-terminus and b-turn linker
in Tycko’s fibril model, respectively. The two segments
17-23 and 34-35 showing most HX protection are both
located entirely within the two intramolecular b-strands of
fibrils. However, the disagreement between two studies is
also observed in the C-terminal region spanning residues
35–40, which has been noted and discussed previously by
Wetzel et al. (26). The unexpectedly elevated solvent acces-
sibility in the C-terminal segment 35-40, despite its high
hydrophobicity, could be attributed to the lack of a rigid
assembly structure in this region even in maturely developed
fibrils, which has also been suggested by limited proteolysis
(49), proline and cysteine scanning mutagenesis (32,50), and
HX-NMR (30).
Relative to the aggregated form of HMW oligomers,
fibrillar Ab only differs by a significantly reduced solvent
accessibility in the N-terminal region 1-16 (Fig. 5 b). The
small change in local solvent accessibility is surprising given
the major change in aggregate morphology of our HMW
oligomers to mature fibrils. Our previous analysis by EM
and AFM indicates our HMW oligomers are predominantly
spherical or disk-like in morphology, with 9–25 nm lateralBiophysical Journal 96(3) 1091–1104
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fibrils (13,25). These morphologies are also predominant in
the current samples (see new EM images in Fig. S3). Other
groups have also observed such morphologies at
intermediate stages of aggregation (18–20). Shorter fibrils/
protofibrils may be present and may be important intermedi-
ates in the process of fibril formation; they are just not the
predominant species at 4–10 h under our aggregation
conditions. Thus, at least under some aggregation conditions,
there is significant restructuring in the aggregates from
spheres or disks to fibrils.
Why might there be such a small difference in solvent
accessibility patterns when the morphologies of spherical
oligomers are so different from fibrils? One explanation
would be that HMW oligomers and fibrils are constructed
by building blocks that are very similar in molecular level
b-sheet structures, but different arrangements of such
structures that have weak solvent protection between them.
Two previous studies, one conducted by using high resolu-
tion AFM (18), and the other by molecular simulation
(52), support this interpretation. They proposed disk-like or
annular structural models for intermediate oligomers, in
which Ab molecules have the same fundamental b-hairpin
structure as those in fibrils. Our measurements of identical,
reduced solvent accessibility in region 17-40 suggests that
the fundamental structure of building molecules in HMW
oligomers and fibrils is located in the C-terminal beta-strand
forming region, in good agreement with these two oligomer
models. The solvent accessibility reduction within region
1-16 in fibrils could be due to extension of b-sheet structure
into the mainly disordered N-terminus. Such an extension of
b strands would be consistent with our measured increases in
b-sheet content (Fig. 6) and the fibril model obtained by
Tycko et al. (31) using solid state NMR.
The structure features of HMW oligomers
and correlation with their high neurotoxicity
The structural data of our HMW oligomers can be related to
previous models of large spherical Ab oligomers. First, our
HX data disagree with the micelle-like structure model
proposed for HMW oligomers (10,53). According to that
model, the C terminus of Ab peptides in large oligomer
structure is assumed to be deeply buried in the interior hydro-
phobic core, thus solvent shielded to a greater extent than in
the fibrillar state (53). However, our observations show that
the C-terminal reporter peptide 35-40 from HMW oligomers
is highly solvent exposed in all the three aggregated states,
second only to the N-terminal peptide 1-16 in HMW olig-
omer structure (Table 1).
Second, the HMW oligomers formed under our Ab(1-40)
aggregation conditions seem to be structurally different from
the calmidazolium chloride (CLC) stabilized protofibrils
investigated by Wetzel et al. (26,36). Though these two
aggregated forms have a similar overall solvent accessibilityBiophysical Journal 96(3) 1091–1104based on intact Ab HX measurement, the peptide level
solvent accessibility pattern differs significantly between
each other. In our measurement, 23.3 5 0.9 deuterium can
be labeled into HMW oligomers within 1 h compared to
26.2 5 1.0 deuterium into CLC-stabilized protofibrils after
1 day exchange. The deuterium labeling into Wetzel’s proto-
fibrils changed only slightly with the labeling time, and
decreased to between 24 and 25, an extent of labeling closer
to our data, if the labeling time was shortened to 1 h (36). Our
HMW oligomers showed a significantly higher degree of
deuterium labeling (15.6 5 0.4) than Wetzel’s protofibrils
(12.4 5 0.6) in reporter peptide 1-19, but a lower degree
in reporter peptide 20-34 (5.9 5 0.3 for HMW oligomers
vs. 9.5 5 0.4 for protofibrils) (26). Nevertheless, both our
HMW oligomers and Wetzel’s CLC-stabilized protofibrils
show some basic fibril-like structural features, such as Congo
Red binding ability (Fig. 7) and being rich b-sheet structure
(Fig. 6). This indicates that HMW oligomers might be
a certain form of transient precursor leading to protofibrils
and fibrils, for instance, the building blocks to form protofi-
bril structure (7).
Our HX data together with CD measurements also
provide what we believe is new insight into the structure
basis responsible for the varying degrees of neurotoxicity
associated with distinct aggregated Ab forms (10,13,24).
First, it has been suggested that the neurotoxicity of Ab
aggregation is correlated with the development of b-sheet
structure in the formed aggregate structure (54). Consistent
with that, Ab monomer and LMW oligomers in freshly
prepared sample that showed almost no effect on SY5Y
cell viability (13) have little or no b-sheet secondary
structure. As for the other two aggregated forms (HMW
oligomers and fibrils), both developed substantial b-sheet
structure. However, the additional structural difference in
the N-terminal region between HMW oligomer and fibril
may lead to the observed different neurotoxicity (13). As
shown in Fig. 5 b, the maturely developed Ab fibrils differ
mainly from HMW oligomers by a more solvent shielded
N-terminal region 1-16, where most charged residues are
located. As a consequence, the electrostatic interaction
between Ab fibrils and cell membrane might be attenuated.
Reducing electrostatic interactions generally between Ab
and membrane has been demonstrated to cause a reduction
in the Ab peptide toxicity (55). Another proposed mecha-
nism of Ab neurotoxicity involves generation of reactive
oxidative species (ROS), caused by binding of metal ions
such as Fe2þ and Cu2þ to Ab peptides at sites His6, His13,
and His14 (56). The solvent shielded structure of peptide
1-16 in Ab fibrils may block the access of metal ions to these
binding sites, particularly His13 and His14, and thus inhibit
the pathway of ROS generation in vivo. Conversely, the
highly neurotoxic HMW oligomers have a more flexible
and solvent accessible N-terminus, which allows the electro-
static interaction of Ab peptides with membrane and metal
ion binding.
Ab(1-40) Structure by HX-MS 1103In summary, the peptide level HX-MS has been success-
fully applied to the Ab(1-40) aggregation system. The struc-
tural differences between multiple aggregated states were
identified at a high spatial resolution. A correlation between
local structure features and neurotoxicity of Ab peptide at
different aggregated forms was implied, providing what we
believe is new insight for the rational development of thera-
peutic strategies for AD.
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